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Prognostic models play a crucial role in the clinical decision-making process. Unfortunately, missing covariate data impede the
construction of valid and reliable models, potentially introducing bias, if handled inappropriately. The extent of missing covariate data
within reported cancer prognostic studies, the current handling and the quality of reporting this missing covariate data are unknown.
Therefore, a review was conducted of 100 articles reporting multivariate survival analyses to assess potential prognostic factors,
published within seven cancer journals in 2002. Missing covariate data is a common occurrence in studies performing multivariate
survival analyses, being apparent in 81 of the 100 articles reviewed. The percentage of eligible cases with complete data was
obtainable in 39 articles, and was o90% in 17 of these articles. The methods used to handle incomplete covariates were obtainable
in 32 of the 81 articles with known missing data and the most commonly reported approaches were complete case and available case
analysis. This review has highlighted deficiencies in the reporting of missing covariate data. Guidelines for presenting prognostic studies
with missing covariate data are proposed, which if followed should clarify and standardise the reporting in future articles.
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Prognostic models formalise the multivariate relationships be-
tween multiple patient characteristics and outcome and can be
useful tools to aid clinical decision-making. The construction of a
prognostic model ideally requires a large database with complete
information on all potential prognostic factors. However, often
some cases have missing covariate data, which may introduce bias
and lead to misleading conclusions if handled inappropriately.
There are many strategies available for handling missing data
(Little and Rubin, 1987; Schafer and Graham, 2002). These include
the simple deletion approaches of complete case analysis, where
only the cases with complete data for all collected variables are
analysed, available case analysis, where the cases with complete
data for the variables in the fitted model are analysed utilising the
largest possible data set, and variable omission (Vach, 1997),
where the incomplete variable is excluded from the model. Other
techniques, utilising all cases, include analysing the missing data as
a separate category (Greenland and Finkle, 1995), single imputa-
tion (Little and Rubin, 1987), in which a single value is substituted
for each missing value, and multiple imputation (Rubin, 1987;
Schafer, 1997), where more than one independently completed
data sets are obtained. Each strategy for handling missing data has
an underlying assumption regarding the missing data mechanism
(Little and Rubin, 1987), that is, the reasons for the occurrence of
the missing covariate data, which if not satisfied could result in
biased parameter estimates. For example, the commonly used
complete case analysis assumes that the missingness in the
covariates is not associated with the outcome (Vach and Blettner,
1998). Most single imputation and multiple imputation approaches
assume that the missingness is related to the observed data but
does not depend on the unobserved value itself.
A review of cancer studies was undertaken to assess the quality
of reporting missing covariate data when constructing prognostic
models, to establish the extent of missing covariate data, and to
review the current handling of this potentially serious problem.
Guidelines for reporting prognostic studies with missing covariate
data are proposed.
METHODS
A sample of 100 articles was obtained using fairly broad inclusion
criteria. Articles were included if they were published in 2002 within
the seven non-review clinical cancer journals with the highest impact
factors; for each journal, searching ceased if 20 articles were
identified. A multivariate survival analysis must have been
performed to establish the factors affecting prognosis, with at least
four covariates considered for potential inclusion. Prognosis could
be measured in terms of overall survival, disease-specific survival or
disease-free survival. There were no restrictions placed on the sample
size, the type of cancer studied or the type of study, allowing both
prognostic modelling and prognostic factor studies to be included.
The seven journals were hand searched to identify articles that
met the inclusion criteria. The journals, with the associated
number of articles obtained from each in brackets, were the
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www.bjcancer.comJournal of the National Cancer Institute (nine articles), Journal of
Clinical Oncology (20 articles), International Journal of Cancer (16
articles), British Journal of Cancer (12 articles), Cancer (20
articles), European Journal of Cancer (11 articles) and Annals of
Oncology (12 articles).
A data extraction form was designed to collect the required
information and one reviewer extracted all the data. For articles
reporting more than one multivariate survival analysis, preference
was placed on the results for overall survival, using the whole
sample and not a subgroup and on the results for the construction
sample and not the validation set.
RESULTS
The 100 articles described studies in a range of cancer sites, the
most common sites being breast cancer (25 articles) and cancers of
the digestive organs (22 articles). The articles reported the results
from cohort studies (76 articles), randomised trials (11 articles),
selection of cases from one or more randomised trials (10 articles),
case-controlled studies (two articles) and a case–cohort study (one
article). Results were extracted from analyses of overall survival
(81 articles), disease-specific survival (11 articles) and disease-free
survival (eight articles).
Table 1 provides a summary of the key data and multivariate
modelling issues. The total number of eligible cases, satisfying the
individual study’s inclusion criteria, was reported in 87 articles,
and ranged from 29 to 20561 patients. The amount of censoring
ranged from 8 to 93% for the 48 articles where this could be
ascertained.
All articles employed Cox proportional hazards modelling with
the exception of two: one performed a regression tree analysis
(Ciampi et al, 1995) and the other used an accelerated failure time
model (Harrell, 2001). The choice of candidate variables for
potential inclusion in the multivariate survival analysis was
discussed in 69 articles. In five of these articles the variables with
a large amount of missingness, that is, 425% of values, were
excluded from potential inclusion in the model. The number of
candidate variables investigated was obtained from 79 articles and
ranged from two to 23 variables with a median of six variables.
Missing covariate data
Overall, the presence or absence of missing covariate data could be
established in 96 articles (Figure 1). There was insufficient
information in the remaining four articles, since there was no
patient characteristic table (one article), not all variables were
reported (one article) or only summary measures were provided
(two articles). Complete data were reported in 15 articles; two
articles reported the results from randomised trials and the
remaining 13 were retrospective selections of patients with tumour
specimen available or specific tests undertaken. Thus, missing data
was an exclusion criterion in these 13 studies, but the actual
amount of missingness was not specified. In the remaining 81
articles, there was evidence of some missing covariate data.
Additionally, in 27 of these 81 articles, there was an inclusion
criterion of availability of tumour specimens or data, with 11
articles not specifying the number of cases this criterion excluded.
Table 2 provides a summary of the reporting of missing
covariate data within these 100 reviewed articles. The percentage of
complete cases out of the total number eligible was extracted from
39 articles as a means to quantify the amount of cases with any
missing covariate data. In 52 articles the amounts of missingness,
if any, were specified for all the reported variables; 15 with no
missing data reported and 37 with some missingness. The extent of
missing data was established solely from the text in one article and
from tables provided in the remaining 51 articles. The information
reported within the tables was either the total number of cases with
data for each covariate (eight articles), the observed number of
cases within each category (31 articles) or a separate unknown
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Total number of eligible events 48
Choice of candidate variables 69
Number of candidate variables 79
Cox proportional hazards model used 98
How covariates handled in analysis 29
Verifying model assumptions 23








data in four articles
13 had availability




Figure 1 Flow diagram showing the presence or absence of missing covariate data.




Proportion of complete cases 39
Number of incomplete variables 68
Maximum missingness in any variable 70
Amounts of missingness for all variables 52
Methods for handling missingness 32
Reasons for missingness 21
Comparison between complete cases and
those with incomplete data
10
Specific missing data section 1
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data was supplemented by the percentage of missing data. For 48
articles the full extent of the missingness could not be determined,
as there was either no patient characteristics table (eight articles)
or insufficient information in the tables (40 articles).
Quantification of completeness of covariate data
The percentage of eligible cases with complete data was less than
90% in 17 of the 39 articles, where this was determined. The
minimum percentage of complete cases was 41%. The number of
incomplete variables ranged from none in 15 articles to 30
incomplete covariates in one article, with a median of three
incomplete variables reported per article. Also, the variable with
the maximum amount of missingness had more than 10% of its
values missing in over half of the 70 articles, where this was
ascertained (36 articles). The maximum amount of missingness in
any one variable was 72%.
Approaches for handling missing covariate data
In 32 (38%) of the 81 articles with known missing data, at least one
method for handling covariates with missing data was mentioned
(Table 2), although five of these 32 articles only reported the
handling of some, but not all, of the incomplete covariates. The
most commonly reported approaches were complete case analysis
(12 articles) and available case analysis (12 articles). In addition,
six articles omitted between one and four variables due to missing
data and four articles included cases with missing values as a
separate category within the modelling procedure. In three of the
reviewed articles the authors applied an informal single imputation
approach, substituting the missing values with values from
surrogate variables (two articles) or with the median values
calculated from the non-missing data for the covariates in the final
model (one article). Multiple imputation was reported in just one
article.
The number of cases analysed and associated number of events
were given in four of the 32 articles where the approach used to
handle the missing data could be determined, and in a further 11
articles where there were no missing data. However, the number of
events per variable considered was only sufficient to provide
reliable and unbiased results, that is, greater than 10 events per
candidate variable (Peduzzi et al, 1995), in five of these 15 articles.
Exploration of the missing data mechanism
The possible reasons for any missingness were discussed in 21
articles (Table 2), the main reason being the lack of availability of
tissue samples (17 articles). Other reasons were that the covariate
was not collected by design for all patients in the study (two
articles) or the inability to determine a response due to contra-
indications to the required procedure (two articles).
The existence of any differences between the complete and
incomplete cases was discussed in 10 articles (Table 2); six of these
articles considered differences in patient and clinical character-
istics, one compared survival, and three compared both patient
characteristics and survival. Differences were found between those
patients with complete data and those with missing data in seven
of these articles. In an additional article, the authors reported that
there were no differences in characteristics between the complete
cases and the whole sample.
DISCUSSION
Impact of missing data
Missing data can introduce bias depending on the missing data
mechanism and the adopted missing data approach. This can lead
to under- or overestimation of the parameter estimates, which may
affect the prognostic ability of the covariates and change the
study’s conclusions. Excluding cases with missing data reduces the
analysable sample size and wastes valuable information that has
been collected. Consequently, the power to determine significant
covariates is reduced, variances are overestimated and confidence
intervals are too wide (Little and Rubin, 1987). Conversely,
including all cases without accounting for the fact that the data
were unknown, for example, with single imputation, overstates the
available sample size, leading to an underestimation of the
variance and hence too narrow confidence intervals and more
significant P-values (Rubin, 1987). Multiple imputation results in
valid statistical inferences that properly reflect uncertainty due to
missing values (Schafer, 1997).
The amount of missing data apparent in a study can provide a
measure of the quality of a study. Studies having a lot of
missingness may be considered of poorer quality than those with
none or limited missing data. It is the responsibility of the authors
to provide sufficient information to allow readers the ability to
make an assessment of the study’s quality and hence reliability of
the obtained results.
Frequency and handling of missing covariate data
This review has established that missing covariate data is a
common occurrence in cancer studies performing multivariate
survival analyses. Missing data was an issue in almost all of the
reviewed prognostic studies, but its impact was explored in only a
minority. Only 10 out of the 100 articles explored the differences in
characteristics or outcome between the cases with complete or
incomplete data.
The most commonly reported methods for handling missing
covariate data were complete case analysis and available case
analysis, regardless of the amount of missingness or possible
missing data mechanisms. It is likely that the majority of articles
not reporting the methods for handling the missing covariate data
used these simple deletion techniques as well.
Three articles applied informal single imputation approaches
and then analysed the data, assuming that these values were the
true observed values, without consideration of the problems
associated with not accounting for the missing data uncertainty
(Rubin, 1987). Only one article reported using a multiple
imputation approach, which was used when there were five
incomplete covariates with a range of missingness from 0.5 to 6%.
No specific details of the multiple imputation approach were
provided in the article, and the reference cited (Harrell and Shih,
2001) did not relate to multiple imputation. However, multiple
imputation was performed in this study using the TRANSCAN
function (Harrell, 2001) within S-Plus 2000 (Insightful Corp,
Seattle, WA) (personal communication).
Reporting missing covariate data
This review has highlighted important deficiencies in the reporting
of missing covariate data. In the majority of articles the extent of
missing covariate data is unclear. The methods used to handle
missing covariate data were obtainable in only 40% of the articles
with apparent missing data. Very few articles made it clear how
many cases were actually analysed and the associated number of
events. Only one article included a separate section devoted to
missing data. We are concerned that very few authors have
considered the impact of missing covariate data; it seems that
missing data is generally either not recognised as an issue or
considered a nuisance that it is best hidden.
It was not the objective of this study to consider the
methodological issues regarding the construction of prognostic
models or the appropriate results to report. Previous articles have
provided recommendations for the reporting of studies using
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presenting of prognostic factor studies (Simon and Altman, 1994;
Altman and Lyman, 1998; Riley et al, 2003). Unfortunately, the
current review shows that earlier recommendations are still not
generally followed, leaving the readers of many articles unclear
about many important aspects regarding how the authors
performed the survival analysis.
We are unaware of any guidelines specifically for the reporting
of missing covariate data, although guidelines exist for reporting
quality of life end points, which include that the amounts of
missing data and their possible causes should be documented
along with how they are analysed (Staquet et al, 1996). Therefore,
we have proposed guidelines for reporting prognostic studies with
missing covariate data (Figure 2), which should supplement the
specific recommendations for prognostic modelling (Simon and
Altman, 1994; Altman and Lyman, 1998; Riley et al, 2003). For
readers to quantify the completeness of covariate data, the number
of cases deemed ineligible due to the unavailability of data should
be provided. The total number of eligible cases and the number
with complete data should also be stated, allowing the proportion
of eligible cases with complete data to be calculated. Ideally, as
previously stated in guidelines for reporting survival analyses
(Altman et al, 1995), the frequency of missing data for every
variable collected should be reported, which can easily be
incorporated into a patient characteristics table. However, if there
is only a small amount of overall missingness (e.g. 490% of cases
with complete data), then the total number of incomplete variables
and the maximum amount of missingness in any variable may
suffice. The method adopted to handle missing data for every
incomplete covariate should be clearly stated, with sufficient
details of any imputation strategies to allow readers to know how
the method was performed and, if desired, apply the methodology
elsewhere. Appropriate references should be given for any
imputation method used. For each analysis, the number of cases
included and the associated number of events should also be
provided, as previously suggested by Riley et al (2003). Finally, any
known reasons for the missing data should be discussed and the
results of any comparisons of characteristics between the cases
with complete data and those with incomplete data presented. This
information allows readers to make informed judgements regard-
ing the potential missingness mechanism and hence the appro-
priateness of the applied methods.
The overall reporting quality of the 100 articles within the
current review according to the suggested guidelines is displayed
in Figure 3. Only 12 studies would have satisfied the proposed
guidelines for reporting the extent of missing covariate data and
Quantification of completeness of covariate data
Approaches for handling missing covariate data
Exploration of the missing data
If availability of data is an inclusion criterion, specify the number of cases excluded for this reason
Provide the total number of eligible cases and the number with complete data
Report the frequency of missing data for every variable considered. If there is only a small amount
of overall missingness (e.g. >90% of cases with complete data), then the number of incomplete









Provide sufficient details of the methods adopted to handle missing covariate data for all
incomplete covariates
Give appropriate  references for any imputation method used
For each analysis, specify the number of cases included and the associated number of events
Discuss any known reasons for missing covariate data
Present the results of any comparisons of characteristics between the cases with without
missing data
Figure 2 Guidelines for reporting prognostic studies with missing covariate data.
100 articles reviewed
24 articles excluded unknown number of ineligible cases due
to incomplete covariate data
Six articles did not specify the number of eligible cases
47 articles did not specify the number of eligible cases with
complete data
11 articles did not report frequency of missing data for all
variables
12 articles satisfied the criteria for reporting
Two articles also satisfied the criteria for reporting the
One article also satisfied the criteria for reporting 
the exploration of the missing covariate data
the completeness of covariate data
Seven articles did not provide details of the methods used to
One article had missing covariate data but failed to comment of
handle all incomplete covariates
Three articles did not specify the number of cases analysed and
the associated number of events
approaches for handling missing covariate data
the possible reasons for the missing data
Figure 3 Flow diagram showing adherence to proposed guidelines.
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for reporting the approaches used for handling incomplete
covariate data. One of these studies had some missing covariate
data, but unfortunately failed to comment on the possible
mechanisms resulting in the missing data, and one was a
randomised trial with no evidence of missing covariate data and
therefore exploration of the missing data was not required.
Therefore, only one article provided all the information considered
important regarding the quantification, handling and exploration
of missing covariate data, and hence satisfied the proposed
guidelines for reporting missing covariate data when constructing
prognostic models.
It is evident that better quality reporting of prognostic studies is
required, especially with missing covariate data being an issue in
the majority of reviewed studies. The proposed guidelines for
presenting prognostic studies with missing covariate data, if
followed, should help to contribute to the improved reporting in
future articles.
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Appendix A
Summary reference details for the 100 articles reviewed are
provided in Table A1.
Table A1
Journal Volume Start page
Ann Oncol 13 308,523,1017,1087,1275,1364,1454,1460,1550,1568,1621,1779
Br J Cancer 86 31,331,396,674,1899
Br J Cancer 87 8,281,756,772,1140,1404,1422
Cancer 94 14,125,264,344,352,386,421,658,746,752,854,873,940,973,1049,1121,1886,2180,2813,2836
Eur J Cancer 38 401,511,527,1059,1065,1181,1329,1343,1502,1860,1987
Int J Cancer 97 512,518,574,770
Int J Cancer 98 415,879,883,900,916
Int J Cancer 99 100,418,579,589,
Int J Cancer 100 290,452,463
J Clin Oncol 20 42,179,221,231,247,254,289,680,707,732,776,1353,1368,1721,1793,2076,2633,2672,2930,3972
J Natl Cancer Inst 94 26,116,284,490,662,1091,1160,1569,1635
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